High-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. [electronic resource]
Producer: 20130812Description: 169-79 p. digitalISSN:- 1876-7605
- Age Factors
- Aged
- Aged, 80 and over
- Aryl Hydrocarbon Hydroxylases -- genetics
- Atorvastatin
- Blood Platelets -- drug effects
- Chi-Square Distribution
- Clopidogrel
- Coronary Artery Disease -- blood
- Cytochrome P-450 CYP2C19
- Drug Interactions
- Drug Resistance
- Female
- Heptanoic Acids -- administration & dosage
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Italy
- Male
- Middle Aged
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Pharmacogenetics
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Function Tests
- Prospective Studies
- Purinergic P2Y Receptor Antagonists -- administration & dosage
- Pyrroles -- administration & dosage
- Receptors, Purinergic P2Y12 -- blood
- Risk Assessment
- Risk Factors
- Ticlopidine -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.